ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
5.02
+0.22 (4.58%)
Mar 10, 2026, 4:08 PM HKT
-11.93% (1Y)
| Market Cap | 2.07B |
| Revenue (ttm) | 134.60M |
| Net Income (ttm) | -331.67M |
| Shares Out | 431.51M |
| EPS (ttm) | -0.84 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,406,200 |
| Average Volume | 1,485,020 |
| Open | 4.68 |
| Previous Close | 4.80 |
| Day's Range | 4.68 - 5.30 |
| 52-Week Range | 3.43 - 16.80 |
| Beta | 0.97 |
| RSI | 59.85 |
| Earnings Date | Mar 25, 2026 |